TGTX
#989
TG Therapeutics, Inc. - Common Stock
54.3 4 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.68%
Variación mensual
+1.40%
Variación en los últimos 6 meses
+56.33%
Cambio anual
+59.21%
Cierres anteriores
55.2 7
Open
55.2 3
Mínimo
53.6 3
Máximo
55.3 2
Financials
- Market Capitalization 8.32 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
10.76
Relación precio/flujo de caja
7.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 956 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 106.68 USD | -4.82% | +2.01% | -6.83% | +80.51% | 8.87 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 61.62 USD | -1.86% | +0.87% | -14.57% | +6.06% | 8.57 B USD | ||
| 994 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 58.13 USD | -4.28% | -5.68% | -29.81% | +48.67% | 8.21 B USD | ||
| 995 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 156.32 USD | -5.83% | -10.16% | -27.30% | +20.06% | 8.19 B USD |